[Cost effectiveness--radiation-induced telangiectasia treated with the Hyfrecator].
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000191:economics / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004598:Electrosurgery / Q000191:economics / Q000295:instrumentation* / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D011788:Quality of Life; D011832:Radiation Injuries / Q000191:economics / Q000601:surgery*; D011878:Radiotherapy / Q000009:adverse effects* / Q000191:economics; D012867:Skin / Q000528:radiation effects*; D013684:Telangiectasis / Q000191:economics / Q000209:etiology* / Q000601:surgery*; D016896:Treatment Outcome